A taxonomy for disease management - A scientific statement from the American Heart Association Disease Management Taxonomy Writing Group

被引:201
|
作者
Krumholz, Harlan M.
Currie, Peter M.
Riegel, Barbara
Phillips, Christopher O.
Peterson, Eric D.
Smith, Renee
Yancy, Clyde W.
Faxon, David P.
机构
关键词
AHA Scientific Statements; disease management; chronic disease; delivery of health care; classification; heart failure;
D O I
10.1161/CIRCULATIONAHA.106.177322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Disease management has shown great promise as a means of reorganizing chronic care and optimizing patient outcomes. Nevertheless, disease management programs are widely heterogeneous and lack a shared definition of disease management, which limits our ability to compare and evaluate different programs. To address this problem, the American Heart Association's Disease Management Taxonomy Writing Group developed a system of classification that can be used both to categorize and compare disease management programs and to inform efforts to identify specific factors associated with effectiveness. Methods-The AHA Writing Group began with a conceptual model of disease management and its components and subsequently validated this model over a wide range of disease management programs. A systematic MEDLINE search was performed on the terms heart failure, diabetes, and depression, together with disease management, case management, and care management. The search encompassed articles published in English between 1987 and 2005. We then selected studies that incorporated (1) interventions designed to improve outcomes and/or reduce medical resource utilization in patients with heart failure, diabetes, or depression and (2) clearly defined protocols with at least 2 prespecified components traditionally associated with disease management. We analyzed the study protocols and used qualitative research methods to develop a disease management taxonomy with our conceptual model as the organizing framework. Results-The final taxonomy includes the following 8 domains: (1) Patient population is characterized by risk status, demographic profile, and level of comorbidity. (2) Intervention recipient describes the primary targets of disease management intervention and includes patients and caregivers, physicians and allied healthcare providers, and healthcare delivery systems. (3) Intervention content delineates individual components, such as patient education, medication management, peer support, or some form of postacute care, that are included in disease management. (4) Delivery personnel describes the network of healthcare providers involved in the delivery of disease management interventions, including nurses, case managers, physicians, pharmacists, case workers, dietitians, physical therapists, psychologists, and information systems specialists. (5) Method of communication identifies a broad range of disease management delivery systems that may include in-person visitation, audiovisual information packets, and some form of electronic or telecommunication technology. (6) Intensity and complexity distinguish between the frequency and duration of exposure, as well as the mix of program components, with respect to the target for disease management. (7) Environment defines the context in which disease management interventions are typically delivered and includes inpatient or hospital-affiliated outpatient programs, community or home-based programs, or some combination of these factors. (8) Clinical outcomes include traditional, frequently assessed primary and secondary outcomes, as well as patient-centered measures, such as adherence to medication, self-management, and caregiver burden. Conclusions-This statement presents a taxonomy for disease management that describes critical program attributes and allows for comparisons across interventions. Routine application of the taxonomy may facilitate better comparisons of structure, process, and outcome measures across a range of disease management programs and should promote uniformity in the design and conduct of studies that seek to validate disease management strategies.
引用
收藏
页码:1432 / 1445
页数:14
相关论文
共 50 条
  • [21] Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association
    Jone, Pei-Ni
    Ivy, D. Dunbar
    Hauck, Amanda
    Karamlou, Tara
    Truong, Uyen
    Coleman, Ryan D.
    Sandoval, Juan Pablo
    del Cerro Marin, Maria Jesus
    Eghtesady, Pirooz
    Tillman, Kathryn
    Krishnan, Usha S.
    CIRCULATION-HEART FAILURE, 2023, 16 (07)
  • [22] Congenital Heart Disease in the Older Adult A Scientific Statement From the American Heart Association
    Bhatt, Ami B.
    Foster, Elyse
    Kuehl, Karen
    Alpert, Joseph
    Brabeck, Stephen
    Crumb, Stephen
    Davidson, William R., Jr.
    Earing, Michael G.
    Ghoshhajra, Brian B.
    Karamlou, Tara
    Mital, Seema
    Ting, Jennifer
    Tseng, Zian H.
    CIRCULATION, 2015, 131 (21) : 1884 - 1931
  • [23] Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association
    Ferriero, Donna M.
    Fullerton, Heather J.
    Bernard, Timothy J.
    Billinghurst, Lori
    Daniels, Stephen R.
    DeBaun, Michael R.
    deVeber, Gabrielle
    Ichord, Rebecca N.
    Jordan, Lori C.
    Massicotte, Patricia
    Meldau, Jennifer
    Roach, E. Steve
    Smith, Edward R.
    STROKE, 2019, 50 (03) : E51 - E96
  • [24] Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association
    Hopper, Rachel K.
    Hansmann, Georg
    Hollander, Seth A.
    Dipchand, Anne I.
    van der Have, Oscar
    Iler, Colleen
    Herrington, Cynthia
    Rosenzweig, Erika B.
    Alejos, Juan C.
    Tran-Lundmark, Karin
    CIRCULATION-HEART FAILURE, 2025, 18 (01)
  • [25] Sexual Activity and Cardiovascular Disease A Scientific Statement From the American Heart Association
    Levine, Glenn N.
    Steinke, Elaine E.
    Bakaeen, Faisal G.
    Bozkurt, Biykem
    Cheitlin, Melvin D.
    Conti, Jamie Beth
    Foster, Elyse
    Jaarsma, Tiny
    Kloner, Robert A.
    Lange, Richard A.
    Lindau, Stacy Tessler
    Maron, Barry J.
    Moser, Debra K.
    Ohman, E. Magnus
    Seftel, Allen D.
    Stewart, William J.
    CIRCULATION, 2012, 125 (08) : 1058 - 1072
  • [26] Palliative Pharmacotherapy for Cardiovascular Disease: A Scientific Statement From the American Heart Association
    Di Palo, Katherine E.
    Feder, Shelli
    Baggenstos, Yleana T.
    Cornelio, Cyrille K.
    Forman, Daniel E.
    Goyal, Parag
    Kwak, Min Ji
    Mcilvennan, Colleen K.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2024, 17 (08):
  • [27] Chronic Heart Failure in Congenital Heart Disease A Scientific Statement From the American Heart Association
    Stout, Karen K.
    Broberg, Craig S.
    Book, Wendy M.
    Cecchin, Frank
    Chen, Jonathan M.
    Dimopoulos, Konstantinos
    Everitt, Melanie D.
    Gatzoulis, Michael
    Harris, Louise
    Hsu, Daphne T.
    Kuvin, Jeffrey T.
    Law, Yuk
    Martin, Cindy M.
    Murphy, Anne M.
    Ross, Heather J.
    Singh, Gautam
    Spray, Thomas L.
    CIRCULATION, 2016, 133 (08) : 770 - 801
  • [28] Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association
    Chow, Sheryl L.
    Bozkurt, Biykem
    Baker, William L.
    Bleske, Barry E.
    Breathett, Khadijah
    Fonarow, Gregg C.
    Greenberg, Barry
    Khazanie, Prateeti
    Leclerc, Jacinthe
    Morris, Alanna A.
    Reza, Nosheen
    Yancy, Clyde W.
    CIRCULATION, 2023, 147 (02) : E4 - E30
  • [29] Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke A Scientific Statement for Healthcare Professionals From the American Heart Association
    Riegel, Barbara
    Moser, Debra K.
    Buck, Harleah G.
    Dickson, Victoria Vaughan
    Dunbar, Sandra B.
    Lee, Christopher S.
    Lennie, Terry A.
    Lindenfeld, JoAnn
    Mitchell, Judith E.
    Treat-Jacobson, Diane J.
    Webber, David E.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (09):
  • [30] State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association
    Liu, Yi-Ching
    Lin, Ming-Tai
    Wang, Jou-Kou
    Wu, Mei-Hwan
    PEDIATRICS AND NEONATOLOGY, 2018, 59 (06): : 543 - 552